Cargando…

HLA-DQ restricted activation of nitroso-sulfamethoxazole-specific CD4+ T-lymphocytes

Detalles Bibliográficos
Autores principales:	Ogese, Monday, Saide, Katy, Whitaker, Paul, Peckham, Daniel, Faulkner, Lee, Alfirevic, Ana, Pirmohamed, Munir, Park, Kevin, Naisbitt, Dean
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127557/ http://dx.doi.org/10.1186/2045-7022-4-S3-P110

Ejemplares similares

Characterization of Teicoplanin-Specific T-Cells from Drug Naïve Donors Expressing HLA-A*32:01
por: Gardner, Joshua, et al.
Publicado: (2022)

Abs No: HLA-A*31:01 positive hypersensitive patient
por: Lichtenfels, Maike, et al.
Publicado: (2014)

Deciphering Adverse Drug Reactions: In Vitro Priming and Characterization of Vancomycin-Specific T Cells From Healthy Donors Expressing HLA-A*32:01
por: Ogese, Monday O, et al.
Publicado: (2021)

Negative regulation by Programmed Death Ligand-1 during drug-specific priming of T-cells and the influence of Programmed Death-1 on effector T-cell function
por: Gibson, Andrew, et al.
Publicado: (2014)

Identification of susceptible HLA class II co-amoxiclav genotypes based on the analysis of drug-specific T-cells from patients with liver injury
por: Saide, Katy, et al.
Publicado: (2014)

Characterization of amoxicillin and clavulanic-acid-responsive CD4+ And CD8+ T-cells in patients with co-amoxiclav-induced liver injury
por: Kim, Seung-Hyun, et al.
Publicado: (2014)

Establishment of an HLA-typed cohort of 1000 healthy blood donors and use of a dendritic cell priming assay to prime naive T cells to structurally divergent drugs
por: Faulkner, Lee, et al.
Publicado: (2014)

Dapsone‐ and nitroso dapsone‐specific activation of T cells from hypersensitive patients expressing the risk allele HLA‐B*13:01
por: Zhao, Qing, et al.
Publicado: (2019)

Activation of human CD8+ T-cells with nitroso dapsone-modified HLA-B*13:01-binding peptides()
por: Almutairi, Mubarak, et al.
Publicado: (2023)

Characterization of Drug-Specific CD4(+) T-Cells Reveals Possible Roles of HLA Class II in the Pathogenesis of Carbamazepine Hypersensitivity Reactions
por: Jaruthamsophon, Kanoot, et al.
Publicado: (2023)

Drug Induced Hypersensitivity and the HLA Complex
por: Alfirevic, Ana, et al.
Publicado: (2010)

Skewing of the TCR V repertoire in SMX-NO specific T cell responses
por: Faulkner, Lee, et al.
Publicado: (2014)

Isoniazid-specific T-cell Responses in patients with anti-tuberculosis drug related liver injury
por: Usui, Toru, et al.
Publicado: (2014)

The incidence of HLA-DQ2/DQ8 in Turkish children with celiac disease and a comparison of the geographical distribution of HLA-DQ
por: Basturk, Ahmet, et al.
Publicado: (2017)

HLA-DQ2 and -DQ8 genotype frequency in Syrian celiac disease children: HLA-DQ relative risks evaluation
por: Murad, Hossam, et al.
Publicado: (2018)

In silico analysis of HLA associations with drug-induced liver injury: use of a HLA-genotyped DNA archive from healthy volunteers
por: Alfirevic, Ana, et al.
Publicado: (2012)

HLA-DQ-Specific Recombinant Human Monoclonal Antibodies Allow for In-Depth Analysis of HLA-DQ Epitopes
por: Bezstarosti, Suzanne, et al.
Publicado: (2022)

Antigen exposure required for T cell activation
por: Meng, Xiaoli, et al.
Publicado: (2014)

Assessing the Prevalence of HLA-DQ2 and HLA-DQ8 in Lipedema Patients and the Potential Benefits of a Gluten-Free Diet
por: Amato, Alexandre C, et al.
Publicado: (2023)

Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules
por: Sollid, Ludvig M., et al.
Publicado: (2012)

THE PREVALENCE OF HLA DQ2 AND DQ8 IN PATIENTS WITH CELIAC DISEASE, IN FAMILY AND IN GENERAL POPULATION
por: CECILIO, Lucila Arantes, et al.
Publicado: (2015)

Meta-Analysis and Systematic Review of HLA DQ2/DQ8 in Adults with Celiac Disease
por: Aboulaghras, Sara, et al.
Publicado: (2023)

Polymorphic DQ alpha and DQ beta interactions dictate HLA class II determinants of allo-recognition
Publicado: (1990)

Enhanced Extracellular Transfer of HLA-DQ Activates CD3(+) Lymphocytes towards Compromised Treg Induction in Celiac Disease
por: Hudec, Michael, et al.
Publicado: (2022)

Characterization of the TCR V repertoire of piperacillin-specific T-cells
por: Al-Attar, Zaid, et al.
Publicado: (2014)

Evaluation of HLA-DQ2/DQ8 genotype in patients with celiac disease hospitalised in 2012 at the Department of Paediatrics
por: Szałowska-Woźniak, Dorota A., et al.
Publicado: (2014)

Human Leukocyte Antigen DQ (HLA‐DQ) genotypes and haplotypes and their association with phenotype in patients with celiac disease in India
por: Ramakrishna, Balakrishnan S, et al.
Publicado: (2021)

Shared Clavulanate and Tazobactam Antigenic Determinants Activate T-Cells from Hypersensitive Patients
por: Ariza, Adriana, et al.
Publicado: (2022)

Peptide binding predictions for HLA DR, DP and DQ molecules
por: Wang, Peng, et al.
Publicado: (2010)

Association of HLA-DR/DQ polymorphisms with schizophrenia in Tunisian patients
por: Sayeh, Aicha, et al.
Publicado: (2014)

HLA-DQ: Celiac disease vs inflammatory bowel disease
por: Bosca-Watts, Marta Maia, et al.
Publicado: (2018)

Immunogenetic Study of Diabetes Mellitus in Relation to HLA DQ and DR
por: Singh, Gyanendra, et al.
Publicado: (2020)

HLA-DQ antibodies in alloimmunity, what makes them different?
por: Meneghini, Maria, et al.
Publicado: (2023)

Fequency distribution of HLA DQ2 and DQ8 in celiac patients and first-degree relatives in Recife, northeastern Brazil
por: Castro-Antunes, Margarida Maria, et al.
Publicado: (2011)

HLA-DQ2 and -DQ8 haplotypes frequency and diagnostic utility in celiac disease patients of Gaza strip, Palestine
por: Ayesh, Basim M., et al.
Publicado: (2017)

Frequency of celiac disease and distribution of HLA-DQ2/DQ8 haplotypes among siblings of children with celiac disease
por: Sahin, Yasin, et al.
Publicado: (2022)

A review of the long-term use of proton pump inhibitors and risk of celiac disease in the context of HLA-DQ2 and HLA-DQ8 genetic predisposition
por: McMillan, Alexandra, et al.
Publicado: (2023)

The frequency of HLA-DQ2/DQ8 haplotypes and celiac disease among the first-degree relatives of patients with celiac disease
por: Mansouri, Masoume, et al.
Publicado: (2021)

Characterization of Magnitude and Antigen Specificity of HLA-DP, DQ, and DRB3/4/5 Restricted DENV-Specific CD4+ T Cell Responses
por: Grifoni, Alba, et al.
Publicado: (2019)

Characterization of anti-drug antibodies and drug-responsive B-lymphocytes in piperacillin hypersensitive patients with cystic fibrosis
por: Amali, Mohammed, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tvv9b79vinule5ucqn9ifn6bm8